That is necessary, since the method a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and work. In other words, we have to know how these proteins fold if we desire a drug to work. Historically, this has actually been an experimental procedure (jeff brown 2021 stock picks). And now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're developed to do. This was a development nearly nobody discovered. But it's going to have profound ramifications for curing disease. I predict that Alpha, Fold will be 98% accurate by the end of 2021.
And, obviously, there will be lots of investment chances in this space, too. Moving subjects It's going to be a great year for bitcoin. I'm bullish on it in 2021 (the legacy report prediction). That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I would not be amazed if it drew back maybe substantially prior to going higher - jeff brown genetic sequencer stock. I've been covering bitcoin for a long period of time now. Among the very first research reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary recommendation, I entitled my report "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time. We were mostly educating readers. However that's not the big question anymore. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. Mass, Mutual is a relied on 170-year-old institution. So think of that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a big reason I'm bullish on it this year. the legacy report predictions. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These business raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I forecast 2021 will be another record year in IPOs. There are a lot of great personal business on the verge of striking the general public markets And I've been working on a new method for you to invest even before these business go public.
This opportunity has actually been constructing over the last few years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to find out all the details. Go right here to book your spot totally free.
Emma Walsh here, handling editor of the Diary. Regular Journal readers know that tech isn't our normal beat (jeff brown predictions 2021). And when it concerns tech investing, we leave it to the professionals. Luckily, we have a number of such experts in our Rolodex. Our coworker Jeff Brown will be familiar to our longtime readers. He is one of the most accomplished tech investing experts we understand (jeff brown stock predictions 2021). In truth, he had numerous triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take a look at the huge image and predict what's just around the corner.
That includes things like 5G networks, biotech, expert system, and much more. These patterns are experiencing exponential growth and developing incredible chances for financiers. I wish to make certain all our readers are gotten ready for what's next. And with that in mind, let me draw the image of what I see can be found in the next 12 months Our new 5G (fifth-generation) cordless networks are a topic I've been covering for years now. jeff brown 1 biotech. But in spite of what numerous readers may think, this is a trend that's just getting going. Although the COVID-19 pandemic interfered with supply chains last year, an outstanding 250 million 5G-enabled devices were still offered.
And all of this eventually led to Apple postponing the release of the 5G-enabled i, Phone 12 by two months (future report review). Losing 2 months of production and sales really affects the number of 5G devices are offered in the calendar year. When you consider all of that, selling 250 million systems is remarkable. More importantly, the delays caused by the pandemic created a lots of bottled-up need. And that need is now going to be pushed into 2021. In truth, I forecast that more than 500 million 5G gadgets will be shipped in 2021 - brownstone research. Which's not my only 5G forecast When I have actually talked about 5G in the past, I've described its 3 different stages.
In Phase 2, 5G devices go on sale. 5G phones and other items begin to reach consumers. And in Phase Three, 5G services start to be provided (jeff brown genome sequencing stock). That's when we begin to see applications operating on 5G networks. Think about things like huge multiplayer games over a smart phone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will begin Stage 3 by this summertime. This begins something of a virtuous cycle: Many people do not truly appreciate the innovation. However they will care if there are amazing applications that can just be accessed with a 5G phone.
That leads to more 5G apps being developed. In truth, 5G is going to open a suite of amazing applications: self-driving cars and trucks, the Internet of Things, robotic surgery, and more. All of these innovations need 5G. The investment chances moving forward will be huge. Stepping far from 5G, the next important technology I predict in 2021 is CRISPR genetic modifying. CRISPR represents "clustered frequently interspaced brief palindromic repeat." It's a mouthful. But it's one of the most exciting developments in biotechnology. At a high level, CRISPR is an innovation that can modify our genetic makeup as if it were software application.
The program can crash or not function properly. CRISPR uses a similar idea but with our hereditary code. "Typos" in our genome can cause disease. CRISPR can remedy these "typos." For years, CRISPR was mainly a specific niche technology that wasn't well comprehended. And throughout that time, there were actually only three business running in this space. But things are altering. CRISPR is no longer simply theoretical. We're seeing real outcomes. We're dealing with diseases and seeing that this innovation just works. And as a result, a "2nd crop" of early-stage CRISPR companies is going public and delivering extraordinary returns. This entire market is successfully a greenfield chance.
There's room for many companies to exist in this space. first lady. And there will be more. That's my prediction for CRISPR in 2021. I predict that 2 or three more hereditary editing business will hold their IPOs. Sticking to biotechnology, we are seeing remarkable things taking place at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its newest Alpha, Fold software application can precisely forecast the folding of a protein based solely on its amino acid series with 92. 4% precision. That is very important since the way a protein in the human body folds determines if a pharmaceutical will have the ability to bind to that protein and be reliable.
Historically, this has been a trial-and-error process. But now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it much simpler to develop drugs that do what they're created to do. And here's my next prediction. I predict that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one but numerous drug therapies produced using this innovation. This was one of those breakthroughs that practically nobody observed. However it's going to have profound implications for treating illness. And, naturally, there will be a lot of financial investment chances in this space, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be shocked if it drew back maybe significantly prior to going greater. I have actually been covering bitcoin for a very long time now. One of the very first research reports I ever published was on bitcoin - jeff brown 2021 stock predictions. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for anybody who followed my recommendation. But at the time of that preliminary suggestion, I entitled my report, "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time.
However nobody is asking that concern any longer. Now, we're seeing institutional money lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. exponential tech investor. Mass, Mutual is a 150-year-old organization. So think of that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus offer forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and declares the details depends on date as of February 2021, but we could not independently verify this claim. Offered Jeff Brown's past, he likely has a considerable net worth, however we can't hammer down a precise figure at this minute. Brown is best understood for his sage-like ability to pick winning innovation stocks. He spent more than 25 years researching technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience offers him an excellent point of view on the market. He's always on the hunt for brand-new chances, and he shares a lot of his best picks in the Future Report.
That's high appreciation, but it's not absurdly reasoned. Brown has an exceptional credibility as a stock-picker, and he successfully forecasted some of the most significant financial occasions of the past twenty years. Although he doesn't appear to release his picks to the general public, the service's success is a direct sign of Brown's stock-picking expertise. No one on Wall Street gets it ideal every time, however Jeff Brown's precise predictions have earned him legions of devoted fans. That states a lot about his ability. The Future Report is published by Brownstone Research, a popular monetary research study publisher. Brownstone Research uses numerous research study services with a wide range of expertises - the legacy report predictions.
The business is also affiliated with Bonner & Partners, another well-respected research publisher - bleeding edge. On its website, Brownstone states its objective is to provide retail financiers with professional-grade research study: "For too long, the very best financial investment research study has not been readily available to private financiers. It has actually been normally reserved for investment banks, hedge funds, personal equity, and high-net-worth clients. last week. The mission of Brownstone Research study is to make that type of exclusive research offered to any investors wanting to acquire an edge in the markets. The goal is easy to deliver special and lucrative financial investment research study found nowhere else." -Brownstone Research website excerpt from the Jeff Brown is the creator of Brownstone Research study, and he likewise serves as the firm's Chief Financial investment Expert.
With Brown directing the ship, Brownstone Research is a powerhouse publisher with lots to offer its clients. After decades of consistent success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a household name throughout most of America. If you understand even a bit about the marketplace, you understand that he has a reputation as a King Midas of sorts. self-driving cars. Whatever he touches turns to gold! Jeff is well mindful of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big task.
In reality, Brown thinks S.A.V. jeff brown genome sequencing stock. could be "the greatest pattern of the 2020s, and he's not alone. Have a look at these quotes from other well-known S.A.V. bulls: Elon's next big act will be weding two innovative technologies: artificial intelligence and electrical cars and trucks. Musk hopes the mix will assist him develop the very first fully-autonomous, self-driving vehicles ever. It's nothing short of the vehicle industry's Holy Grail. As you understand, electric automobiles and self-driving automobile stocks have actually been big this year, however the Wall Street maker has actually approved hype without much concrete result. In spite of an extreme increase in competition over the previous few years, Brown still believes Musk has the very best chance of putting everything together.
tech could be the magic string that connects everything together. S.A.V. represents Shared Autonomous Automobile, and it might be the future of transportation. Essentially, this technology would enable you to rent out your car as an autonomous, self-driving taxi when you're not using it. You just leave the automobile and press a button on an app that informs the cars and truck to "join the fleet." Next thing you understand, you're relaxing on your sofa while your automobile shuttles ride-sharers around town. Most importantly, you get to keep a hefty portion of the earnings. It sounds ridiculous, but it could be closed than you believe.